C
Ching Shyang Chen
Researcher at Taipei Medical University
Publications - 28
Citations - 1111
Ching Shyang Chen is an academic researcher from Taipei Medical University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 15, co-authored 28 publications receiving 983 citations. Previous affiliations of Ching Shyang Chen include Taipei Medical University Hospital.
Papers
More filters
Journal ArticleDOI
Effects of manual lymphatic drainage on breast cancer-related lymphedema: A systematic review and meta-analysis of randomized controlled trials
Tsai Wei Huang,Sung Hui Tseng,Chia Chin Lin,Chyi Huey Bai,Ching Shyang Chen,Chin Sheng Hung,Chih Hsiung Wu,Ka Wai Tam +7 more
TL;DR: The current evidence from RCTs does not support the use of MLD in preventing or treating lymphedema, and clinical and statistical inconsistencies between the various studies confounded the evaluation of the effect ofMLD on breast-cancer-related lyMPhedema.
Journal ArticleDOI
Overexpression and Activation of the α9-Nicotinic Receptor During Tumorigenesis in Human Breast Epithelial Cells
Chia Hwa Lee,Ching Shui Huang,Ching Shyang Chen,Shih Hsin Tu,Ying Jan Wang,Yu Jia Chang,Yu Jia Chang,Ka Wai Tam,Po Li Wei,Tzu Chun Cheng,Jan Show Chu,Jan Show Chu,Li Ching Chen,Chih Hsiung Wu,Chih Hsiung Wu,Yuan Soon Ho,Yuan Soon Ho +16 more
TL;DR: The alpha9-nAChR is important for nicotine-induced transformation of normal human breast epithelial cells and triggered precancerous transformation as defined by soft agar assay.
Journal ArticleDOI
Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins
Ching Shyang Chen,Chia-Hwa Lee,Chang Da Hsieh,Chi-Tang Ho,Min-Hsiung Pan,Ching Shui Huang,Shih Hsin Tu,Ying Jan Wang,Li-Ching Chen,Yu Jia Chang,Po-Li Wei,Yi Yuan Yang,Chih-Hsiung Wu,Yuan Soon Ho +13 more
TL;DR: The homeostatic regulation of cyclin D3 has the potential to be a molecular target for antitumor chemotherapeutic or chemopreventive purposes in clinical breast cancer patients.
Journal ArticleDOI
Increased expression of enolase α in human breast cancer confers tamoxifen resistance in human breast cancer cells
Shih Hsin Tu,Chih Chiang Chang,Ching Shyang Chen,Ching Shyang Chen,Ka Wai Tam,Ying Jan Wang,Chia Hwa Lee,Hsiao Wei Lin,Tzu Chun Cheng,Ching Shui Huang,Jan Show Chu,Neng Yao Shih,Li Ching Chen,Sy Jye Leu,Yuan Soon Ho,Chih Hsiung Wu +15 more
TL;DR: The data presented here demonstrate that those patients whose tumors highly expressed ENO-1 had a poor prognosis with greater tumor size, poor nodal status, and a shorter disease-free interval, and suggest that downregulation of ENo-1 could be utilized as a novel pharmacological approach for overcoming 4-OHT resistance in breast cancer therapy.
Journal ArticleDOI
Crosstalk between nicotine and estrogen-induced estrogen receptor activation induces α9-nicotinic acetylcholine receptor expression in human breast cancer cells.
Chia Hwa Lee,Ya Chieh Chang,Ching Shyang Chen,Shih Hsin Tu,Ying Jan Wang,Li Ching Chen,Yu Jia Chang,Yu Jia Chang,Po Li Wei,Po Li Wei,Hui Wen Chang,Chien Hsi Chang,Ching Shui Huang,Chih Hsiung Wu,Yuan Soon Ho,Yuan Soon Ho +15 more
TL;DR: It is observed that breast tumors with higher α9-nAChR mRNA expression levels were associated with the lowest 5-year disease-specific survival rate, and in vitro promoter-binding assays demonstrated that the ER is a major transcription factor that mediates nicotine- and E2-induced up-regulation of α 9-n AChR gene expression in MCF-7 cells.